Toolkit/OsTIR1 S210A variant

OsTIR1 S210A variant

Construct Pattern·Research·Since 2025

Also known as: S210A

Taxonomy: Mechanism Branch / Architecture. Workflows sit above the mechanism and technique branches rather than replacing them.

Summary

This directed protein evolution generates several gain-of-function OsTIR1 variants, including S210A, that significantly enhance the overall degron efficiency.

Usefulness & Problems

Why this is useful

S210A is an evolved OsTIR1 variant reported to significantly enhance overall degron efficiency. It is one of several gain-of-function variants produced by the directed evolution campaign.; enhancing degron efficiency

Source:

S210A is an evolved OsTIR1 variant reported to significantly enhance overall degron efficiency. It is one of several gain-of-function variants produced by the directed evolution campaign.

Source:

enhancing degron efficiency

Problem solved

It helps improve degron performance relative to the starting OsTIR1-based system.; improves overall degron efficiency

Source:

It helps improve degron performance relative to the starting OsTIR1-based system.

Source:

improves overall degron efficiency

Problem links

improves overall degron efficiency

Literature

It helps improve degron performance relative to the starting OsTIR1-based system.

Source:

It helps improve degron performance relative to the starting OsTIR1-based system.

Published Workflows

Objective: Compare inducible protein degradation systems and engineer an improved auxin-inducible degron system that preserves strong depletion while reducing basal degradation and improving recovery after ligand washout.

Why it works: The workflow first identifies the strongest starting degradation platform by direct comparison, then uses mutagenesis and repeated functional selection/screening to evolve receptor variants that improve the specific liabilities of the starting system.

inducible target protein degradationimproved recovery after ligand washoutsystematic comparisonbase-editing-mediated mutagenesisfunctional selectionscreeningdirected protein evolution

Stages

  1. 1.
    Comparative assessment of five inducible degradation systems(broad_screen)

    This stage identifies the strongest starting degradation system for further engineering.

    Selection: Comparison across degradation efficiency, basal degradation, target recovery after ligand washout, and ligand impact.

  2. 2.
    Base-editing-mediated mutagenesis of OsTIR1(library_build)

    This stage creates candidate OsTIR1 variants for directed evolution.

    Selection: Generate OsTIR1 variant diversity to address basal degradation and slow recovery limitations of AID 2.0.

  3. 3.
    Several rounds of functional selection and screening(selection)

    This stage enriches for improved OsTIR1 variants after mutagenesis.

    Selection: Functional performance of OsTIR1 variants in the degron system.

  4. 4.
    Resulting improved degron system characterization(confirmatory_validation)

    This stage confirms that the evolved system improves on the starting AID 2.0 tradeoffs.

    Selection: Demonstrate effective depletion with minimal basal degradation and faster recovery after washout in the resulting system.

Steps

  1. 1.
    Benchmark five inducible degradation systems across shared performance criteria

    Identify the most robust starting system for further engineering.

    A comparative benchmark is performed first so the engineering campaign starts from the strongest available platform rather than mutating an inferior baseline.

  2. 2.
    Mutagenize OsTIR1 by base editingengineering method

    Create OsTIR1 variant diversity to overcome AID 2.0 limitations.

    Mutagenesis follows system selection because the authors first identify AID 2.0 as the best baseline and then engineer its limiting component.

  3. 3.
    Perform several rounds of functional selection and screening on OsTIR1 variantsengineered variants under selection

    Enrich for gain-of-function OsTIR1 variants with improved degron performance.

    Selection and screening occur after mutagenesis because variant diversity must first be generated before improved variants can be enriched.

  4. 4.
    Characterize the resulting AID 2.1 system for depletion, basal degradation, and recoveryresulting engineered degron system

    Confirm that the evolved system improves the key tradeoffs observed in AID 2.0.

    Final characterization is done after variant selection to verify that the evolved system delivers the intended performance improvements in the finished tool.

Taxonomy & Function

Primary hierarchy

Mechanism Branch

Architecture: A reusable architecture pattern for arranging parts into an engineered system.

Target processes

editingrecombinationselection

Implementation Constraints

cofactor dependency: cofactor requirement unknownencoding mode: genetically encodedimplementation constraint: context specific validationoperating role: regulator

The abstract indicates that this variant arises from base-editing-mediated mutagenesis and is used as an OsTIR1 component in the degron system.; must be used as an OsTIR1 variant within the degron system

Independent follow-up evidence is still limited. Validation breadth across biological contexts is still narrow. Independent reuse still looks limited, so the evidence base may be fragile. No canonical validation observations are stored yet, so context-specific performance remains under-specified.

Validation

Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication

Supporting Sources

Ranked Claims

Claim 1comparative performancesupports2025Source 1needs review

Among the five inducible protein degradation systems compared, OsTIR1-based AID 2.0 was identified as the most robust system.

This analysis identifies OsTIR1-based AID 2.0 as the most robust system.
Claim 2method outcomesupports2025Source 1needs review

Base-editing-mediated mutagenesis followed by several rounds of functional selection and screening generated gain-of-function OsTIR1 variants that significantly enhanced overall degron efficiency.

This directed protein evolution generates several gain-of-function OsTIR1 variants, including S210A, that significantly enhance the overall degron efficiency.
Claim 3performance improvementsupports2025Source 1needs review

AID 2.1 maintains effective target protein depletion while reducing basal degradation and accelerating recovery after ligand washout.

The resulting degron system, named AID 2.1, maintains effective target protein depletion with minimal basal degradation and faster recovery after ligand washout
Claim 4tradeoffsupports2025Source 1needs review

AID 2.0 combines higher degradation efficiency with target-specific basal degradation and slower recovery after ligand washout.

However, AID 2.0's higher degradation efficiency comes with target-specific basal degradation and slower recovery rates.
Claim 5use casesupports2025Source 1needs review

AID 2.1 enables characterization and rescue experiments for essential genes in dynamic biological contexts.

enabling characterization and rescue experiments for essential genes. Our comparative assessment and directed evolution approach provide a reference dataset and improved degron technology for studying gene functions in dynamic biological contexts.

Approval Evidence

1 source1 linked approval claimfirst-pass slug ostir1-s210a-variant
This directed protein evolution generates several gain-of-function OsTIR1 variants, including S210A, that significantly enhance the overall degron efficiency.

Source:

method outcomesupports

Base-editing-mediated mutagenesis followed by several rounds of functional selection and screening generated gain-of-function OsTIR1 variants that significantly enhanced overall degron efficiency.

This directed protein evolution generates several gain-of-function OsTIR1 variants, including S210A, that significantly enhance the overall degron efficiency.

Source:

Comparisons

Source-backed strengths

gain-of-function OsTIR1 variant; significantly enhances overall degron efficiency

Source:

gain-of-function OsTIR1 variant

Source:

significantly enhances overall degron efficiency

OsTIR1 S210A variant and intron-containing CRISPRa construct address a similar problem space because they share editing, recombination.

Shared frame: same top-level item type; shared target processes: editing, recombination

OsTIR1 S210A variant and optimized prime editing strategy address a similar problem space because they share editing, selection.

Shared frame: same top-level item type; shared target processes: editing, selection

Compared with synthetic promoters

OsTIR1 S210A variant and synthetic promoters address a similar problem space because they share editing, recombination, selection.

Shared frame: same top-level item type; shared target processes: editing, recombination, selection

Relative tradeoffs: appears more independently replicated; looks easier to implement in practice.

Ranked Citations

  1. 1.

    Extracted from this source document.